Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in overweight and obese patients with dengue
NCT04377451Phase 2Completed
- Sponsor
- Oxford University Clinical Research Unit
- Start
- Jul 2020
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of metformin in dengue fever, sponsored by Oxford University Clinical Research Unit. Primary endpoint: Number of adverse events at 30 days. Started Jul 2020; status: completed.
02
Drugs
metformin
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT04377451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04377451.